{{Rsnum
|rsid=2281389
|Gene=HLA-DPB2
|Chromosome=6
|position=33092019
|Orientation=minus
|GMAF=0.141
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 2.7 | 26.5 | 70.8
| HCB | 0.0 | 19.0 | 81.0
| JPT | 2.7 | 27.4 | 69.9
| YRI | 0.0 | 4.8 | 95.2
| ASW | 0.0 | 19.3 | 80.7
| CHB | 0.0 | 19.0 | 81.0
| CHD | 0.0 | 22.0 | 78.0
| GIH | 0.0 | 27.7 | 72.3
| LWK | 0.0 | 14.5 | 85.5
| MEX | 3.4 | 20.7 | 75.9
| MKK | 1.9 | 24.5 | 73.5
| TSI | 3.9 | 36.3 | 59.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=21596858
|Title=Multiple Hodgkin lymphoma-associated loci within the HLA region at chromosome 6p21.3
}}

{{PMID Auto
|PMID=17903301
|Title=Genome-wide association of echocardiographic dimensions, brachial artery endothelial function and treadmill exercise responses in the Framingham Heart Study.
|OA=1
}}

{{PMID Auto
|PMID=18309376
|Title=Several regions in the major histocompatibility complex confer risk for anti-CCP-antibody positive rheumatoid arthritis, independent of the DRB1 locus.
|OA=1
}}

{{PMID Auto
|PMID=19143813
|Title=Confirmation of HLA class II independent type 1 diabetes associations in the major histocompatibility complex including HLA-B and HLA-A.
|OA=1
}}

{{PMID Auto
|PMID=19458352
|Title=Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants.
|OA=1
}}

{{PMID|22837536|OA=1
}} acute graft-versus-host disease (GVHD)

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}